percutaneous coronary interventions
Title. National Audit of Percutaneous Coronary Interventions. Annual Public Report. 1 National Audit of Percutaneous Coronary Interventions
... of Percutaneous Coronary Interventions We established a STEMI Pathway Improvement Team which consisted of visiting local trusts and walking their pathways, developing a 24/7 Cardiac Pathway Team, a ...
37
Predictors of Complications after Sheath Removal Post Transfemoral Percutaneous Coronary Interventions
... post percutaneous coronary interventions (PCI) are more threatening than it was previously thought so that necessary measures should be taken to minimize those ...
8
2015 Procedural Reimbursement Guide Select Percutaneous Coronary Interventions Interventional Cardiology
... Hospital Outpatient Billing and Payment: Medicare reimburses hospitals for outpatient stays (typically stays of less than two midnights) under Ambulatory Payment Classification (APC) groups. Medicare assigns an APC to a ...
11
Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality
... of coronary artery perforation (CAP) during percutaneous coronary interventions (PCI) is estimated at ...emergency coronary artery bypass grafting (CABG), and ...
70
Incidence and Predictors of Contrast-induced Nephropathy in Patients Undergoing Percutaneous Coronary Interventions at an Indian Tertiary Care Center
... undergoing percutaneous coronary ...underwent percutaneous coronary ...undergoing percutaneous coronary ...undergoing percutaneous coronary ...
8
Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions
... Conclusions: Greater GV is associated with composite MACE and non-IRA revascularization during in-hospital and 30-day follow-up in unadjusted analyses, especially for diabetic subjects. After multivariable logistic ...
12
Guidelines for Percutaneous Coronary Interventions
... for coronary angiogra- phy and, if applicable, primary PCI in another hospital, because PCI might be their only chance for quickly opening the coronary ...
44
Platelet Inhibition in Percutaneous Coronary Interventions
... ing coronary balloon angioplasty (PTCA) were ran- domized to either aspirin (990 mg daily) and dipyri- damole (225 mg daily) or placebo starting 24 h prior to the procedure and continuing for 4–7 months thereaf- ...
8
Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
... We searched the EMBASE, PubMed, MEDLINE, BIOS, International Pharmaceutical Abstracts database, and ISI Web of Science databases from 1980 to 15 July 2011. In addition, abstract lists and conference proceedings from the ...
11
StentBoost Visualization for the Evaluation of Coronary Stent Expansion During Percutaneous Coronary Interventions
... All patients underwent PCI completely in accordance with the normal routine from December 2010 to December 2011. Thirty-eight patients underwent PCI and were included in the present analysis. All clinical decisions ...
10
2014 Procedural Reimbursement Guide Select Percutaneous Coronary Interventions
... + C9605 Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary [r] ...
10
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
... T Percutaneous coronary intervention (PCI) is effective in opening the infarct related artery and restoring thrombolysis in myocardial infarction flow 3 (TIMI-flow 3) in large majority of ST-elevation ...
13
The effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventions
... A limitation to these fi ndings is the retrospective nature of the data. Although the data were analysed retrospect- ively it was collected prospective and included all patients consecutively presenting for ...
9
A Systematic Review of Gender Differences in Mortality after Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions
... Knowledge of the reasons for gender differences in out- comes after coronary revascularization can optimize therapy for all patients. The relative importance of factors in mediating these gender differences, ...
5
Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions
... main coronary artery (LMCA) involvement and separate LMCA disease in all patient ...of coronary artery lesions in‑ cluding distribution, bifurcations, and chronic total occlusions ...
11
CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions
... Mehran et al 4 investigated a cohort of 5571 patients who underwent PCI [35.7% with acute coronary syndrome (ACS)], and established a popular scoring system for risk stratification for CIN. MRS comprised eight ...
9
Contemporary use of and outcomes associated with ultra‐low contrast volume in patients undergoing percutaneous coronary interventions
... Trends in contrast vol- ume use and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention: Insights from blue cross blue shield of Michigan cardiovas[r] ...
9
Percutaneous coronary intervention in Europe 1992-2003
... Percutaneous coronary interventions in Europe 1992-2003 Stéphane Cook, Mario Togni, Nazan Walpoth, Willibald Maier, Volker Muehlberger, Victor Legrand, Davor Milicic, Costakis Zambartas, Michal ...
6
Elective percutaneous coronary intervention in the elderly patient
... of coronary disease, age remained the strongest predictor of in-hospital ...undergoing percutaneous coronary interventions: results in 7472 octogenarians: National Cardiovascular Network ...
33
Distal protection devices during percutaneous coronary and carotid interventions
... graft interventions, when GP IIb/IIIa inhibitors clearly reduce procedural infarctions by approximately 50%, is the differ- ence in the composition of the embolic ...of interventions on vein grafts that are ...
6